Web1 day ago · IRVINE, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering ... WebNov 3, 2024 · Medpace Holdings has an estimated growth rate of 22.7% for 2024. MEDP’s earnings surpassed estimates in the trailing four quarters, the average being 22.04%. Merit Medical, flaunting a Zacks ...
Inari Medical (NARI) Stock Price, News & Info The Motley Fool
WebMay 5, 2024 · Inari revenues for the first quarter of 2024 were $86.8 million, representing a 4% sequential growth, compared to $83.2 million for Q4 of '21 and up $29.4 million or 51% from $57.4 million for... WebMay 5, 2024 · Inari Medical, Inc. (NARI) Q1 2024 Earnings Call Transcript. 407%. Our Most Popular Articles. Why C3.ai Stock Was Surging Today. 1 Monster Growth Stock That Could Turn $200,000 Into $1 Million by ... small cell carcinoma ovary hypercalcemic type
NARI Earnings Date 2024 Inari Medical Earnings Forecast
WebMay 12, 2024 · Inari Medical, Inc. (NARI-3.58%) Q1 2024 Earnings Call May 11, 2024, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared ... Web1 day ago · Inari Medical (NARI) Q4 Earnings Beat, Revenues Rise Y/Y 03/01/23-4:18AM EST Zacks ... Inari Medical: Reinvesting Heavily Into Growing International Markets 03/03/23-2:02AM EST Seeking Alpha. WebApr 6, 2024 · NARI Earnings Date and Information. Inari Medical last released its earnings data on February 27th, 2024. The reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.06. The business had revenue of $107.77 million for the quarter, compared to analysts' expectations of $104.85 million. small cell carcinoma path outlines